Impella use in acute myocardial infarction complicated by cardiogenic shock and cardiac arrest: Analysis of 10 years registry data

Davidsen, Cedric; Packer, Erik; Løland, Kjetil Halvorsen; Rotevatn, Svein; Nygreen, E; Eriksen, Erlend; Øksnes, Anja; Herstad, Jon; Haaverstad, Rune; Bleie, Øyvind; Tuseth, Vegard

doi:10.1016/j.resuscitation.2019.04.022

Cited by 22 publications

(14 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The past few years have witnessed a considerable growth of new imaging modalities and adjunctive therapies for the pre and postoperative support of MI-MC [3,5,6,[13][14][15]. However, most studies are limited to single-center experiences and by relatively small sample sizes.…”

Section: Introductionmentioning

confidence: 99%

In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Patients with cardiac arrest and ongoing CPR who were treated with Impella have been reported to have very high mortality rates 4 . Among our three cases, two patients with OHCA treated using Impella showed good neurological prognosis.…”

Section: Discussionmentioning

confidence: 60%

“…P ATIENTS WITH CARDIAC arrest and ongoing CPR who were treated with Impella have been reported to have very high mortality rates. 4 Among our three cases, two patients with OHCA treated using Impella showed good neurological prognosis. In patients with cardiogenic OHCA, the use of Impella as a part of resuscitation could lead to improved prognosis of the patient's life and neurological outcome.…”

Section: Discussionmentioning

confidence: 63%

Saving patients with out‐of‐hospital cardiac arrest using Impella: three case reports

Aida

Azuma

Ishii

et al. 2020

Acute Medicine & Surgery

View full text Add to dashboard Cite

We report three cases of using Impella that saved the life of patients with out‐of‐hospital cardiac arrest. For applying Impella in these patients, it is necessary to consider the age, initial rhythm, witness, bystander cardiopulmonary resuscitation, time from onset to hospital arrival, hemodynamics after intra‐aortic balloon pump introduction, and transthoracic echocardiography findings at arrival.

show abstract

“…The different technical features of the various MCS device may constitute an obstacle in the selection of the assist device, since the size of the sheath and the diameter of the femoral or axillary artery could determine the incision site as well as the type of the device that nary embolism [23][24][25][26][27][28][29][30][31][32][33][34][35]. In patients with end-stage heart failure or in severe cases of myocarditis, Impella seems to be highly effective as a bridge both to recovery or to a final treatment, such as transplantation or surgical heart pump implantation [26,27].…”

Section: Insertion and Accurate Placement In The LVmentioning

confidence: 99%

“…Several published studies demonstrated the significant circulatory support and anti-ischemic myocardial protection that Impella could provide in the context of high-risk PCI [29][30][31][32]. Recent studies suggest the use of Impella devices in patients with CS or cardiac arrest caused by AMI in order to improve outcomes [33,34]. The early implantation of Impella prior to PCI is associated with prolonged survival and higher rates of successful revascularization [35].…”

Section: Insertion and Accurate Placement In The LVmentioning

confidence: 99%

Left Ventricular Assist Devices and Their Role in Cardiogenic Shock: Literature Review and Contemporary Data

Tzikas¹,

Ap²,

Boulmpou³

et al. 2021

Int J Clin Cardiol

View full text Add to dashboard Cite

Despite tremendous progress in the therapeutic algorithms of hemodynamically unstable patients, cardiogenic shock remains a clinical challenge with high mortality rate. Conservative management with inotropic agents remains the first-choice treatment, though it has been associated with serious adverse events and is not always adequate. Circulatory support with mechanical devices has been widely implemented in patients with cardiogenic shock during high-risk percutaneous coronary interventions or post-cardiac surgery complications and has been associated with favorable outcomes. In patients with acute decompensated heart failure, ventricular assist devices have been used to prolong the recovery period and reverse the cause of hemodynamic instability. In the present review, we discuss the current evidence on the use of percutaneous assist devices for the treatment of cardiogenic shock, plus we highlight the need for future evolution in this particular field that may permit the optimal choice of each device for different patients or clinical situations.

show abstract

Impella use in acute myocardial infarction complicated by cardiogenic shock and cardiac arrest: Analysis of 10 years registry data

Cited by 22 publications

References 23 publications

In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

Saving patients with out‐of‐hospital cardiac arrest using Impella: three case reports

Left Ventricular Assist Devices and Their Role in Cardiogenic Shock: Literature Review and Contemporary Data

Contact Info

Product

Resources

About